First-in-human results of terbium-161 [16ªTb]Tb-PSMA-I&T dual beta-Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET):a single-centre, single-arm, phase 1/2 study

2025年9月24日